Pharmacokinetics of the raltegravir/maraviroc/etravirine combination

J Antimicrob Chemother. 2011 Aug;66(8):1932-4. doi: 10.1093/jac/dkr219. Epub 2011 Jun 4.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Anti-HIV Agents / administration & dosage
  • Anti-HIV Agents / pharmacokinetics*
  • Antiretroviral Therapy, Highly Active / methods*
  • Cyclohexanes / administration & dosage
  • Cyclohexanes / pharmacokinetics*
  • Female
  • HIV Infections / drug therapy*
  • Humans
  • Male
  • Maraviroc
  • Middle Aged
  • Nitriles
  • Pyridazines / administration & dosage
  • Pyridazines / pharmacokinetics*
  • Pyrimidines
  • Pyrrolidinones / administration & dosage
  • Pyrrolidinones / pharmacokinetics*
  • Raltegravir Potassium
  • Salvage Therapy / methods
  • Triazoles / administration & dosage
  • Triazoles / pharmacokinetics*

Substances

  • Anti-HIV Agents
  • Cyclohexanes
  • Nitriles
  • Pyridazines
  • Pyrimidines
  • Pyrrolidinones
  • Triazoles
  • etravirine
  • Raltegravir Potassium
  • Maraviroc